Immune tolerance induction in MS patients with neutralizing antibodies
Immune tolerance induction in MS patients with neutralizing antibodies against interferon-beta
What it found
No results found
We found no results in the registry or in papers.
What it measured
Main measures
Non-respond of MxA RNA, a biomarker for interferon-beta bioavailability, after 2 infusions of 48 MIU interferon-beta.
Blood or spinal fluid markersImmune responseHow the body handles the medicine
Who could take part
MS (type not specified)
Show the full criteria
Inclusion criteria
Inclusion: diagnosed multiple sclerosis Exclusion: < 18 years old
Exclusion criteria
Not separately supplied in the registry.
As registered. Criteria can change, so ask the trial team or your neurologist.
About this trial
In the sponsor's words
How many multiple slerosis patients show a reduction of the neutralizing antibodies < 100 neutralizing units after 3 months of weekly intravenous interferon-beta infusion.
Loading reviews and guidelines…
History
Started
Nov 2009
Assembled by software from public sources.